genprex.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.genprex.com/sitemap_index.xml # --------------------------- # END YOAST
Meta Tags
Title Genprex - Reprogramming the course of cancer and diabetes and
Description Genprex’s oncology drug development program utilizes its unique, proprietary, non-viral ONCOPREX® Nanoparticle Delivery System, which the Company believes is the first systemic gene therapy delivery platform used for cancer in
Keywords N/A
Server Information
WebSite genprex favicongenprex.com
Host IP 172.67.156.12
Location United States
Related Websites
Site Rank
More to Explore
genprex.com Valuation
US$20,410,598
Last updated: 2023-04-27 22:23:44

genprex.com has Semrush global rank of 518,569. genprex.com has an estimated worth of US$ 20,410,598, based on its estimated Ads revenue. genprex.com receives approximately 2,355,069 unique visitors each day. Its web server is located in United States, with IP address 172.67.156.12. According to SiteAdvisor, genprex.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$20,410,598
Daily Ads Revenue US$18,841
Monthly Ads Revenue US$565,217
Yearly Ads Revenue US$6,782,599
Daily Unique Visitors 157,005
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
genprex.com. A 298 IP: 172.67.156.12
genprex.com. A 298 IP: 104.21.48.189
genprex.com. AAAA 298 IPV6: 2606:4700:3037::ac43:9c0c
genprex.com. AAAA 298 IPV6: 2606:4700:3035::6815:30bd
genprex.com. NS 86400 NS Record: glen.ns.cloudflare.com.
genprex.com. NS 86400 NS Record: yolanda.ns.cloudflare.com.
genprex.com. MX 3600 MX Record: 0 genprex-com.mail.protection.outlook.com.
genprex.com. TXT 300 TXT Record: v=spf1 include:spf.protection.outlook.com -all
genprex.com. TXT 300 TXT Record: google-site-verification=LAuPzxstybywWEICGje9MGp1j0c5lObe2gIN6GIvbQM
HtmlToTextCheckTime:2023-04-27 22:23:44
About Company Management Meet Our Team Board of Directors Scientific Advisory Board Clinical Advisory Board Careers Technologies REQORSA® Immunogene Therapy GPX-002 and GPX-003 ONCOPREX® Nanoparticle Delivery System Programs Oncology Combination Treatment Approach Lung Cancer Diabetes Clinical Trials Pipeline ONC-001 ONC-002 Acclaim-1 Acclaim-2 DIA-001 Expanded Access Policy Investors Overview Company Profile Stock Information SEC Filings Analyst Coverage Corporate Governance Shareholder FAQ Downloads Events News Press Releases Blog Posts Media Coverage Videos Email Alerts Contact About Company Management Meet Our Team Board of Directors Scientific Advisory Board Clinical Advisory Board Careers Technologies REQORSA® Immunogene Therapy GPX-002 and GPX-003 ONCOPREX® Nanoparticle Delivery System Programs Oncology Combination Treatment Approach Lung Cancer Diabetes Clinical Trials Pipeline ONC-001 ONC-002 Acclaim-1 Acclaim-2 DIA-001 Expanded Access Policy Investors Overview Company
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Thu, 21 Oct 2021 02:45:33 GMT
Connection: keep-alive
Cache-Control: max-age=3600
Expires: Thu, 21 Oct 2021 03:45:33 GMT
Location: https://genprex.com/
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=KX%2BvALsyjbPio6yY%2BaLGpkkr5ymCgr8mich3SaYH2GItx8GeYN5i2i8V23Q54FwpRCZeAAlpFXbLUAz1AvkRCg%2BFu5B2VKFnayNKTvyT0Nn8e%2BLzuk08S%2F%2BUfqdjXw%3D%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6a1726848a01fd7e-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400

HTTP/2 301 
date: Thu, 21 Oct 2021 02:45:34 GMT
content-type: text/html; charset=UTF-8
x-redirect-by: WordPress
location: https://www.genprex.com/
vary: User-Agent
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=P8lxixNjG8CRn2OTeuk0Q%2FyCW2TvoIQCjx3WR0O8pctdZ7uV656ucwNorX7UqZc%2BjAmtA8HtvS8%2F0dm9267ft9tMHAe3lkStrQ1d5IXs%2Bj0%2FZmQrcpogZYLnCi6Zvw%3D%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6a172684ef942cc5-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400

HTTP/2 200 
date: Thu, 21 Oct 2021 02:45:35 GMT
content-type: text/html; charset=UTF-8
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
x-tec-api-version: v1
x-tec-api-root: https://www.genprex.com/wp-json/tribe/events/v1/
x-tec-api-origin: https://www.genprex.com
vary: User-Agent
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=o4goc2%2BCYmHrFjYrfk7qfKi0Ctp5Tg11%2FaYfWJu%2Be%2F9tTU5cvGVPsPnjP58TGr23TGAmJPeEjqqJb6A07uBRV1ixsXQHWPxKl2cM8Yokti1DoRr1HtX7ANCicPc4OOlcplA%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6a172689d82dfdd9-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
genprex.com Whois Information
Domain Name: GENPREX.COM
Registry Domain ID: 1645802930_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2019-01-25T17:13:28Z
Creation Date: 2011-03-16T19:05:13Z
Registry Expiry Date: 2024-03-16T19:05:13Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: GLEN.NS.CLOUDFLARE.COM
Name Server: YOLANDA.NS.CLOUDFLARE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-09T19:12:38Z <<<